KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to -$127.0 million.

  • Thermo Fisher Scientific's Deferred Taxes rose 6825.0% to -$127.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 54023.67%. This contributed to the annual value of $1.2 billion for FY2024, which is 700.0% down from last year.
  • Per Thermo Fisher Scientific's latest filing, its Deferred Taxes stood at -$127.0 million for Q3 2025, which was up 6825.0% from -$880.0 million recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Deferred Taxes registered a high of $2.2 billion during Q4 2024, and its lowest value of -$880.0 million during Q2 2025.
  • Moreover, its 5-year median value for Deferred Taxes was $192.0 million (2021), whereas its average is $180.2 million.
  • Per our database at Business Quant, Thermo Fisher Scientific's Deferred Taxes surged by 151250.0% in 2022 and then tumbled by 57252.75% in 2024.
  • Thermo Fisher Scientific's Deferred Taxes (Quarter) stood at $192.0 million in 2021, then tumbled by 30.73% to $133.0 million in 2022, then surged by 403.01% to $669.0 million in 2023, then soared by 231.24% to $2.2 billion in 2024, then crashed by 105.73% to -$127.0 million in 2025.
  • Its Deferred Taxes was -$127.0 million in Q3 2025, compared to -$880.0 million in Q2 2025 and $279.0 million in Q1 2025.